DCM
PRVL

Driehaus Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Driehaus Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-253,970
Closed -$3.35M – 608
2019
Q2 		$3.35M Buy
+253,970
New +$3.35M 0.11% 199